Suppr超能文献

脾切除术可改善血红蛋白H Constant Spring病患者的贫血状况,但不能减轻其铁负荷。

Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease.

作者信息

Zhou Ya-Li, Zhang Xin-Hua, Liu Tie-Niu, Wang Li, Yin Xiao-Lin

机构信息

Department of Haematology, 303rd Hospital of the People's Liberation Army, Nanning, Guangxi, China.

出版信息

Blood Transfus. 2014 Oct;12(4):471-8. doi: 10.2450/2014.0247-13. Epub 2014 Jun 5.

Abstract

BACKGROUND

Splenectomy is reported to increase the haemoglobin level in patients with haemoglobin H Constant Spring (HbH CS) disease; however, its impact on iron burden and the underlying mechanism remains unclear.

MATERIALS AND METHODS

From March through to May 2013, a total of 50 adults with HbH CS disease (25 cases splenectomised and 25 cases non-splenectomised) were enrolled. The patients' general conditions, history of blood transfusion and iron chelator treatment were investigated. Levels of haemoglobin, nucleated red blood cell counts, and serum ferritin were measured. The percentage of apoptotic erythroid precursor cells in bone marrow, an index representing ineffective erythropoiesis, was determined in some cases.

RESULTS

There were no significant differences in age, blood transfusion volume, and use of iron chelator drugs between the splenectomised group and the non-splenectomised group. Significantly higher haemoglobin levels, serum ferritin levels and nucleated red blood cell counts as well as a higher percentage of apoptotic erythroid progenitor cells were detected in the splenectomised group. Regression analysis revealed that age and nucleated red blood cell counts were independent risk factors affecting the serum ferritin level.

DISCUSSION

Despite improving the haemoglobin level, splenectomy is associated with greater iron burden in HbH CS disease. A high nucleated red blood cell count is predictive of the risk of severe iron overload.

摘要

背景

据报道,脾切除术可提高血红蛋白H Constant Spring(HbH CS)病患者的血红蛋白水平;然而,其对铁负荷的影响及潜在机制仍不清楚。

材料与方法

2013年3月至5月,共纳入50例成年HbH CS病患者(25例行脾切除术,25例未行脾切除术)。调查患者的一般情况、输血史和铁螯合剂治疗史。测量血红蛋白、有核红细胞计数和血清铁蛋白水平。部分病例测定骨髓中凋亡红系前体细胞的百分比,这是一个代表无效红细胞生成的指标。

结果

脾切除组与未脾切除组在年龄、输血量和铁螯合剂药物使用方面无显著差异。脾切除组检测到血红蛋白水平、血清铁蛋白水平和有核红细胞计数显著更高,以及凋亡红系祖细胞百分比更高。回归分析显示,年龄和有核红细胞计数是影响血清铁蛋白水平的独立危险因素。

讨论

尽管脾切除术可提高血红蛋白水平,但在HbH CS病中与更大的铁负荷相关。高有核红细胞计数可预测严重铁过载的风险。

相似文献

1
Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease.
Blood Transfus. 2014 Oct;12(4):471-8. doi: 10.2450/2014.0247-13. Epub 2014 Jun 5.
3
Abnormal red blood cell morphological changes in thalassaemia associated with iron overload and oxidative stress.
J Clin Pathol. 2019 Aug;72(8):520-524. doi: 10.1136/jclinpath-2019-205775. Epub 2019 Apr 22.
6
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
Haematologica. 2011 Nov;96(11):1605-12. doi: 10.3324/haematol.2011.047852. Epub 2011 Jul 26.
7
Increased endothelial activation in α-thalassemia disease.
Ann Hematol. 2019 Jul;98(7):1593-1602. doi: 10.1007/s00277-019-03672-4. Epub 2019 Apr 5.
8
Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
Clin Pharmacokinet. 2011 Jan;50(1):41-50. doi: 10.2165/11536630-000000000-00000.
9
Serum ferritin levels in thalassemias and the effect of splenectomy.
Acta Haematol. 1981;66(4):244-50. doi: 10.1159/000207129.

引用本文的文献

1
Cardiovascular Effects of Splenomegaly and Splenectomy in Beta-Thalassemia Major.
Cureus. 2024 Nov 21;16(11):e74186. doi: 10.7759/cureus.74186. eCollection 2024 Nov.
3
Measurement of Erythrocyte Lifespan Using a CO Breath Test in Patients with Thalassemia and the Impact of Treatment.
Mediterr J Hematol Infect Dis. 2023 Sep 1;15(1):e2023050. doi: 10.4084/MJHID.2023.050. eCollection 2023.
5
Clinical and hematological features among β-thalassemia major patients in Jazan region: A hospital-based study.
J Family Med Prim Care. 2020 Jan 28;9(1):412-417. doi: 10.4103/jfmpc.jfmpc_1007_19. eCollection 2020 Jan.

本文引用的文献

1
Glutathione redox system in β -thalassemia/Hb E patients.
ScientificWorldJournal. 2013 Oct 7;2013:543973. doi: 10.1155/2013/543973. eCollection 2013.
3
Study of serum hepcidin in hereditary hemolytic anemias.
Hemoglobin. 2012;36(6):555-70. doi: 10.3109/03630269.2012.721151. Epub 2012 Oct 23.
4
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
Blood Rev. 2012 Apr;26 Suppl 1:S16-9. doi: 10.1016/S0268-960X(12)70006-1.
5
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
Blood Rev. 2012 Apr;26 Suppl 1(0 1):S12-5. doi: 10.1016/S0268-960X(12)70005-X.
7
How I treat thalassemia.
Blood. 2011 Sep 29;118(13):3479-88. doi: 10.1182/blood-2010-08-300335. Epub 2011 Aug 2.
8
Heterogeneity of hemoglobin H disease in childhood.
N Engl J Med. 2011 Feb 24;364(8):710-8. doi: 10.1056/NEJMoa1010174.
9
Optimal management of β thalassaemia intermedia.
Br J Haematol. 2011 Mar;152(5):512-23. doi: 10.1111/j.1365-2141.2010.08486.x. Epub 2011 Jan 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验